DAVID ZACCARDELLI
CIK 1627642 · President and CEO · last filed 2026-01-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$841.9K
Companies
6
Total Filings
103
Lifetime Open-Market Net
-$45.62M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SABSW | Director | — | $0.01 | — | $0 | 1 | 2026-01-07 |
| Verona Pharma plc (VRNA) Delisted | President and CEO | 3,285,280 | $106.91 | $351.23M | -$35.28M | 43 | 2025-10-08 |
| Dova Pharmaceuticals Inc. (DOVA) Delisted | President & CEO | 0 | — | — | -$253.1K | 4 | 2019-11-12 |
| MELINTA THERAPEUTICS, INC. /NEW/ (MLNT) Delisted | Director | 46,500 | — | — | $200.0K | 3 | 2019-06-12 |
| MELINTA THERAPEUTICS, INC. /NEW/ (CEMP) Delisted | Acting Chief Executive Officer | — | — | — | $0 | 2 | 2016-12-13 |
| UTHR | EVP & Chief Operating Officer | 1,542 | $545.96 | $841.9K | -$10.29M | 50 | 2016-05-16 |
Recent Filings · Page 2 of 11
103 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-12-06 | Verona Pharma plc (VRNA) Delisted | Sell (S) | −870,672 | -$4.36M | EDGAR |
| 2024-12-02 | Verona Pharma plc (VRNA) Delisted | Sell (S) | −125,328 | -$627.2K | EDGAR |
| 2024-11-26 | Verona Pharma plc (VRNA) Delisted | Sell (S) | −1,600 | -$8.0K | EDGAR |
| 2024-11-13 | Verona Pharma plc (VRNA) Delisted | Sell (S) | −2,400 | -$12.0K | EDGAR |
| 2024-11-05 | Verona Pharma plc (VRNA) Delisted | Sell (S) | −141,032 | -$618.7K | EDGAR |
| 2024-11-01 | Verona Pharma plc (VRNA) Delisted | Mixed | +754,048 | -$1.04M | EDGAR |
| 2024-10-25 | Verona Pharma plc (VRNA) Delisted | Sell (S) | −144,816 | -$633.9K | EDGAR |
| 2024-10-22 | Verona Pharma plc (VRNA) Delisted | Sell (S) | −514,152 | -$2.25M | EDGAR |
| 2024-09-13 | Verona Pharma plc (VRNA) Delisted | Sell (S) | −600,000 | -$2.25M | EDGAR |
| 2024-08-14 | Verona Pharma plc (VRNA) Delisted | Sell (S) | −400,000 | -$1.28M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.